Moving away from candidate genes: a 'genome-wise' discovery of gemcitabine myelotoxicity.
作者信息
Innocenti Federico
机构信息
University of North Carolina at Chapel Hill, Institute for Pharmacogenomics & Individualized Therapy, Eshelman School of Pharmacy, School of Medicine, Chapel Hill, NC 27599-7361, USA.
出版信息
Pharmacogenomics. 2012 Jul;13(10):1113-4. doi: 10.2217/pgs.12.96.
Abstract
摘要
相似文献
1
Moving away from candidate genes: a 'genome-wise' discovery of gemcitabine myelotoxicity.从候选基因转向：吉西他滨骨髓毒性的“全基因组”发现。
Pharmacogenomics. 2012 Jul;13(10):1113-4. doi: 10.2217/pgs.12.96.
2
Hospitals and communities create 'wise' environments.医院和社区营造“智慧”环境。
Trustee. 1994 Feb;47(2):22-3.
3
Be 'budget-wise'--know computers before you buy.在预算方面要精明——购买前先了解电脑。
J Am Health Care Assoc. 1985 Nov;11(7):64-5.
4
Trends indicate 'wise' integrated systems should embrace complementary medicine.
Health Care Strateg Manage. 1999 Jun;17(6):14.
5
The Pathway Less Traveled: Moving from Candidate Genes to Candidate Pathways in the Analysis of Genome-Wide Data from Large Scale Pharmacogenetic Association Studies.鲜有人走的道路：在大规模药物遗传学关联研究的全基因组数据分析中，从候选基因迈向候选通路
Curr Pharmacogenomics Person Med. 2008;6(3):150-159. doi: 10.2174/1875692110806030150.
6
Working the 'wise' in speech and language therapy: Evidence-based practice, biopolitics and 'pastoral labour'.在言语和语言治疗中运用“智慧”：循证实践、生命政治与“牧领工作”。
Soc Sci Med. 2019 Jun;230:1-8. doi: 10.1016/j.socscimed.2019.03.038. Epub 2019 Mar 26.
7
In silico prediction of drug-induced myelotoxicity by using Naïve Bayes method.使用朴素贝叶斯方法对药物诱导的骨髓毒性进行计算机模拟预测。
Mol Divers. 2015 Nov;19(4):945-53. doi: 10.1007/s11030-015-9613-3. Epub 2015 Jul 11.
8
Gemcitabine and carboplatin regimens in advanced non-small-cell lung cancer: focus on randomized phase III trials.吉西他滨与卡铂联合方案治疗晚期非小细胞肺癌：聚焦随机III期试验
Clin Lung Cancer. 2003 Jan;4 Suppl 2:S40-4. doi: 10.3816/clc.2003.s.002.
9
Clinical and Genetic Factors Associated With Severe Hematological Toxicity in Glioblastoma Patients During Radiation Plus Temozolomide Treatment: A Prospective Study.胶质母细胞瘤患者在放疗联合替莫唑胺治疗期间严重血液学毒性相关的临床和遗传因素：一项前瞻性研究
Am J Clin Oncol. 2015 Oct;38(5):514-9. doi: 10.1097/COC.0b013e3182a790ea.
10
Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia.一名IV期胆管癌患者在接受顺铂和吉西他滨姑息化疗后发生致命性骨髓毒性，尸检诊断为范可尼贫血。
Front Oncol. 2019 May 22;9:420. doi: 10.3389/fonc.2019.00420. eCollection 2019.
引用本文的文献
1
Intergenic SNPs in Obstructive Sleep Apnea Syndrome: Revealing Metabolic, Oxidative Stress and Immune-Related Pathways.阻塞性睡眠呼吸暂停综合征中的基因间单核苷酸多态性：揭示代谢、氧化应激和免疫相关途径
Diagnostics (Basel). 2021 Sep 24;11(10):1753. doi: 10.3390/diagnostics11101753.
本文引用的文献
1
The 8q24 gene desert: an oasis of non-coding transcriptional activity.8q24基因沙漠：非编码转录活性的一片绿洲。
Front Genet. 2012 Apr 30;3:69. doi: 10.3389/fgene.2012.00069. eCollection 2012.
2
Systemic therapies for pancreatic cancer--the role of pharmacogenetics.胰腺癌的系统治疗——药物遗传学的作用。
Curr Drug Targets. 2012 Jun;13(6):811-28. doi: 10.2174/138945012800564068.
3
The limits of genome-wide methods for pharmacogenomic testing.全基因组方法在药物基因组学检测中的局限性。
Pharmacogenet Genomics. 2012 Apr;22(4):261-72. doi: 10.1097/FPC.0b013e328350ca5f.
4
A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapy.一项全基因组关联研究确定了接受吉西他滨治疗的癌症患者血液学毒性的四个遗传标记物。
Pharmacogenet Genomics. 2012 Apr;22(4):229-35. doi: 10.1097/FPC.0b013e32834e9eba.
5
A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303.一项针对接受吉西他滨治疗的胰腺癌患者总体生存的全基因组关联研究，该研究来自 CALGB 80303 试验。
Clin Cancer Res. 2012 Jan 15;18(2):577-84. doi: 10.1158/1078-0432.CCR-11-1387. Epub 2011 Dec 5.
6
Integrating pharmacogenetics into gemcitabine dosing--time for a change?将药物基因组学纳入吉西他滨剂量调整——是时候改变了吗？
Nat Rev Clin Oncol. 2011 Feb 8;8(7):439-44. doi: 10.1038/nrclinonc.2011.1.
7
Clinical pharmacology and pharmacogenetics of gemcitabine.吉西他滨的临床药理学与药物遗传学
Drug Metab Rev. 2009;41(2):77-88. doi: 10.1080/03602530902741828.
8
SLCO1B1 variants and statin-induced myopathy--a genomewide study.溶质载体有机阴离子转运体家族1成员B1（SLCO1B1）变异与他汀类药物诱发的肌病——一项全基因组研究
N Engl J Med. 2008 Aug 21;359(8):789-99. doi: 10.1056/NEJMoa0801936. Epub 2008 Jul 23.
Zotero 插件